udcament

UDCA treat MENT made easy

Each 5 ml contains  Ursodeoxycholic Acid 125 mg In a flavoured Sorbitol base q.s. Colour - Sunset Yellow FCF

Neonatal Cholestasis, Primary Biliary Atresia and viral Hepatitis

10- 15 mg/ kg BID

100 ML

Oral administration of udcament increases this fraction in a dose related manner, to become the major biliary acid, replacing/displacing toxic concentrations of endogenous hydrophobic bile acids that tend to accumulate in cholestatic liver disease. 

It should be stored at room temperature away from light

Some products that may interact with this drug include: Antacids, Cholestyramine, Colestipol, Oestrogens.

Diarrhea, Indigestion, Headache, Nausea or Vomiting, Back pain, Bloody and cloudy urine, Black or tarry stools, Unusual bleeding or bruising, Frequent and/or painful urination, Fever and cough, Hair loss, Swelling of eyelids, face, lips, tongue.